Table 4 Evaluation of clinically treated PRP efficacy using the EoC-ERS2
ERS2 | Patient: RIF/RPL | |||||
|---|---|---|---|---|---|---|
Main-Criteria | Sub-Criteria | Full Points | NT-EoC | PRP treatment | ||
T1-EoC | T2-EoC | T3-EoC | ||||
Endometrial Receptivity | Intensity of Integrin αvβ3 | 5 | 0 | 2 | 4 | 4 |
Intensity of Osteopontin | 5 | 2 | 2 | 2 | 4 | |
Blood vessel formation | Area of angiogenic sprout | 5 | 2 | 3 | 3 | 4 |
Area of blood vessel | 5 | 2 | 2 | 4 | 4 | |
Total | 20 | 6 | 9 | 13 | 16 | |
ERS2 | Â | Non-Receptive | Non-Receptive | Receptive | Receptive | |
IVF-ET outcome prediction | Â | Fail | Fail | Success | Success | |
Clinical pregnancy outcome | Â | Fail | N/A | N/A | N/A (On-hold with issues of collecting good embryos) | |
